Merozoite surface protein 1 of Plasmodium falciparum (MSP-1)

Merozoite surface protein 1 (MSP-1) is the most abundant surface protein on the invasive merozoite stage of Plasmodium falciparum, the causative agent of malaria. MSP-1 is essential for parasite survival, being required for merozoite formation, entry into, and escape from erythrocytes. Produced initially as a large precursor (~190–200 kDa), it is proteolytically cleaved into four major subunits (p83, p30, p38, p42) held together noncovalently, anchored to the membrane via a GPI moiety linked to the p42 subunit. During erythrocyte invasion, most of the complex is shed except for the C-terminal fragment (MSP1_19), which remains attached and contains two epidermal growth factor-like domains. MSP-1 forms complexes with other merozoite proteins and interacts with host cell membrane proteins (such as spectrin), though its direct role in red cell binding remains controversial. It is a major antigenic determinant, making it a leading malaria vaccine candidate, but genetic variability and complex structure pose therapeutic challenges.

Other names

MSP-1PfMSP1Merozoite surface protein 1MSP1_19

Inhibition of erythrocyte invasion: Antibodies or vaccine-induced immunity directed against MSP-1 (particularly MSP1_19) may block proper processing of the protein, preventing parasite entry into red blood cells. Antibody-dependent cellular inhibition (ADCI): Some inhibitory antibodies may activate monocytes to attack infected cells or inhibit merozoite invasion via immune mechanisms.